Targeting STING-ATM axis overcomes radiotherapy-induced immune suppression and restores anti-tumor immunity in nasopharyngeal carcinoma
Tzu-Tung Liu, Kai-Ping Chang, Yunong Wang, Chun‐Nan OuYang, Ming‐Qing Li, Ngan‐Ming Tsang, Shih Sheng Jiang, Yun-Hua Sui, Chun‐Mei Hu, Yung‐Chih Chou, Hsuan-Chung Chen, Shu‐Chen Liu
This study shows that targeting the STING-ATM axis with a STING agonist overcomes radiotherapy-induced immune suppression in nasopharyngeal carcinoma, enhancing anti-tumor immunity and tumor control.
bioRxiv · Nov 12, 2025 · PreprintCancer Biology